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Abstract: Although smoking is an established causal factor for upper aero digestive tract 
cancer (UADTC), most of the evidence originates from the West. Thus, we analysed data 
from 455,409 subjects in the Asia Pacific Cohort Studies Collaboration. Over a median of 
around six years follow-up, 371 deaths from UADTC were observed. The hazard ratio 
(95% confidence interval) for current smokers, compared with those who had never 
smoked, was 2.36 (1.76 – 3.16), adjusted for age and alcohol drinking. Tobacco control 
policies are urgently required in Asia to prevent millions of deaths from UADTC that 
smoking will otherwise cause. 
Keywords: Cancer of the pharynx; cancer of the larynx; cancer of the esophagus; 
smoking; alcohol. 
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1. Introduction  
 
Upper aero-digestive tract (lip, oral cavity, pharynx, esophagus, larynx) cancers are an important 
global problem, particularly in developing countries. Since three-quarters of the nearly one million 
cases of upper aero-digestive tract cancer (UADTC) occurring annually are seen in developing 
countries, UADTC ranks among the five most common cancers in both men and women in these 
settings [1]. Whilst there is considerable variation in survival across the constituent cancers in the 
UADTC group, on average UADTC has one of the lowest figures for five-year survival of all cancers, 
with a range from 10% to 65% [2-4].  
Cigarette smoking is a recognised causal factor for UADTC [2-6]. The excess risk of UADTC 
associated with smoking varies depending on the subtype of cancer and the intensity and duration of 
smoking [7]. Alcohol drinking is the other main risk factor [3,4,6,7], having been reported to increase 
the risk of developing UADTC among non-smokers by more than four times [7]. Combined, these two 
risk factors have been estimated to increase the risk of these cancers by more than twelve times 
compared with individuals who neither smoke nor drink alcohol [7].
  
Most of the data examining the aetiological role of smoking on UADTC are derived from studies in 
Western countries, with few data from populations in eastern and south-eastern Asia (here referred to 
as “Asia”, for brevity). It is not known whether the effects of smoking on the risk of UADTC differ 
substantially between Asian and non-Asian populations. Region-specific information as to the 
magnitude of risks associated with these risk factors would assist public health specialists and policy 
makers in Asia. This is especially relevant, given that the consumption of tobacco in many countries in 
Asia is very high amongst men [8-10], whilst there is an upwards trend in smoking amongst young 
women in some of these countries [11].
 Furthermore, in countries such as China, where more than 60% 
of adult men smoke, the risks associated with smoking are largely unrecognised [9].  
The current paper uses data from the largest collaborative study in the region, the Asia Pacific 
Cohort Studies Collaboration (APCSC), to quantify the risk of mortality from UADTC associated with 
smoking, taking account of potential confounding and modifying effects from alcohol, in populations 
of the Asia-Pacific region.  
 
1.1. Methods 
 
Details of study identification, data collection and event verification for studies in the APCSC are 
described elsewhere [12]. Briefly, studies were included if they had continued follow-up for at least 
5,000 person-years and had recorded vital status at the end of follow-up. Studies were excluded from 
APCSC if entry to that study was dependent upon having a particular medical condition; for this 
current paper only, studies were additionally excluded if they did not record deaths due to UADTC. 
We restricted our analyses to individuals aged 20 or more years at enrolment. Mortality was classified 
according to the 9th Revision of the International Classification of Diseases (ICD): UADTC was 
selected as codes 140-149 (lips, tongue and pharynx; this includes: malignant neoplasms of lip, tongue, 
major salivary glands, gum, floor of mouth, other and unspecified parts of mouth, oropharynx, 
nasopharynx, hypopharynx, other and ill-defined sites within the lip), 150 (esophagus), and 161 
(larynx). Studies were classified as Asian if their participants were recruited from mainland China, Int. J. Environ. Res. Public Health 2009, 6          
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Hong Kong, Japan, Korea, Singapore, Taiwan or Thailand; and ANZ if from Australia or   
New Zealand.  
All data on cigarette smoking and alcohol drinking were based on self-report at the time of entry 
into each of the included studies (‘baseline’). Data recorded on smoking included the number of 
cigarettes currently smoked per day, categorized here into groups of < 20 and > 20 (20 cigarettes 
corresponds to one standard pack), and whether or not non-smokers were former smokers. Alcohol 
was only recorded as current drinking or not. Participants were included in this study only if they 
reported their current and past smoking and current alcohol drinking at baseline. In APCSC, 94% of 
the 600,445 participants recorded their current smoking status, 92% recorded their current drinking 
status and 91% reported both. 
Cox proportional hazard models, stratified by study and sex, and adjusted for age, with and without 
additional adjustment for alcohol, were used to estimate hazard ratios (HRs) associated with smoking 
(current v never, and dose-response) for death due to UADTC and its subtypes. We also estimated HRs 
for overall UADTC by sex, geographical area (Asia/ANZ) and alcohol subgroups, and tested for effect 
modification by including interaction terms in the Cox models [13]. In order to avoid reporting 
unreliable results when the number of events was small, estimates of relative risk for UADTC subtypes 
are not reported for these subgroups. The effect of quitting smoking was estimated through HRs 
comparing ex-smokers with current smokers. All analyses used individual participant data. 
The population attributable risk for mortality from UADTC associated with smoking were 
calculated for each country, for both males and females, using previously published recent prevalence 
estimates of the prevalence of smoking [10] and the formula [13]: PAR = [P (RR-1)]/ [1 + P (RR-1)]. 
Here, the RR was that found from APCSC. 
 
2. Results and Discussion  
 
Of the 44 studies in APCSC, 26 recorded current and past smoking and current drinking at baseline 
as well as deaths from UADTC. These 26 studies (19 from Asia) included 455,409 men and women 
(87% from Asia; 32% female) (Table 1). There were large differences in the percentage of smokers 
between the regions and sexes: 23% and 20% of men and women in ANZ and 59% and 5% of men and 
women in Asia, respectively. On average, smokers in ANZ smoked more cigarettes per day than those 
in Asia: 18 and 15 cigarettes per day in ANZ for men and women, respectively, compared with 15 and 
11 in Asia. The percentage of individuals who reported that they consumed alcohol at study baseline 
also differed by region and by sex: 84% in men and 69% among women in ANZ, and 49% and 9% in 
men and women from Asia. During 2,906,013 person-years of follow up, there were 371 deaths from 
UADTC (176 lip, oral cavity or pharynx, 157 esophagus and 38 larynx; 74% in Asia; 87% male).  
 
2.1. Current Smoking and Risk of Mortality from UADTC  
 
Current smokers had more than twice the risk of mortality from UADTC, compared with never 
smokers: the HR was 2.36 (95% confidence interval, CI: 1.77 – 3.15), adjusted for age. The HR stayed 
the same after further adjustment for alcohol (Figure 1). For each subtype of UADTC, smoking was 
associated with a significant increase in the risk of mortality compared with never smoking. After Int. J. Environ. Res. Public Health 2009, 6          
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adjusting for age and alcohol, the HR was: for lip, oral cavity or pharyngeal cancer, 2.14 (95% CI: 
1.43 – 3.19); esophageal cancer, 2.84 (95% CI: 1.72 – 4.68); laryngeal cancer, 2.59 (95% CI: 1.07 – 
4.68). The association between smoking and overall UADTC death was much stronger in ANZ 
compared with Asia, and in women compared with men (Figure 1). 
 
Table 1. Characteristics at baseline and details of follow-up, for all studies, by region. 
Country Study  Baseline  No. of 
subjects 
Mean 
age 
(yrs) 
Fem
-ale 
(%) 
Current 
drinker
s 
% 
 
Current 
smokers 
(%) 
 
Former 
smoker
s 
(%) 
 
Mean 
cigarettes 
per day 
Media
n 
FU 
(yrs) 
UADT 
cancer 
deaths 
 
M F M F M F  M  F 
Australia Busselton  1966-81  7789 44.9  52  81  57 44 24 25  12 19 16  26.5  34 
Australia Long.  Study 
of Aging 
1992-93  1610 78.1  48 71  58 8  8 62  23 16 13  4.6  3 
Australia National 
Heart 
Foundation 
1989-90 9277  43.5  51  87  75  27  21  32  20  21  16  8.3  12 
Australia Newcastle  1983-94  5929  51.7  50 85  65  28  18  37  18  20  18  8.9  13 
Australia Perth  1978-94  10230  45.0  48 90  75  30  21  31  18  20  16 14.4  9 
Australia WA  AAA 
Screenees 
1996-99 12203  72.2 0  82  -  11  -  60  -  14  -  3.2  22 
 
NZ 
Fletcher 
Challenge 
1992-94 10326  44.3 28  87  77  26  18  33  28  15  13 5.8  4 
ANZ  Subtotal  1966-99 57364  52.0 35  84  69  23  20  42  19  18  15 7.9  97 
China  Anzhen  1991  8378 53.8  55  39   3 51 10 9  2  15  10  4.3  5 
China  Fangshan  1991-92  2619 47.3  67 43 2 75 22 6 2 15  9  3.6  1 
 
China 
Guangzhou 
Occupational 1985-98 166695 41.5  22 
 
27 
 
4 60 1  1 0 15 12  7.3 
 
146 
 
China 
Seven Cities 
Cohorts 1987  10811  53.9  55 
 
42 
 
6 57 17 
 
8 
 
2 
 
- 
 
- 2.7 
 
11 
China  Yunnan  1992  6581 55.8  3  85  70  70 0 14 0 12  -  4.5  9 
Hong 
Kong Hong  Kong  1985-91 
 
2983 
 
78.6 
 
57 
 
24 
 
8 
 
29 
 
11 
 
41 
 
18 
 
13 
 
8 
 
2.5 
 
5 
Japan  Akabane  1985-86  1834 54.5  56 62 5 62 1 21 0 23  9  11.0  1 
 
Japan 
Civil Service 
Workers 1990-92  9240  46.7  33 
 
82 
 
48 51 11 
 
26 
 
3 
 
- 
 
- 6.7 
 
3 
Japan  Hisayama  1961  1601 56.1  56 70 8 76 17 4 1  -  -  24.6  4 
Japan  Konan  1987-95  1226 51.7  55 78  23  62 5 14 1 22 11  6.4  3 
Japan  Ohasama  1992-93  2240 59.5  64 65 8 51 2 11 0  -  -  4.1  2 
Japan  Saitama  1986-90  3615 54.5  62 77  33  63 8 21 2 22 13  11.0  9 
Japan Shibata  1977 2350  56.9  58  72  9  72  4  6  0  20  10  20.0  10 
Japan Shigaraki 
Town 
1991-97  3730 57.1  59 70  19  59 8 22 2 22 13  4.4  4 
Singapore Singapore 
Heart 
1982-97  2321 40.7  49 50  18  41 3 14 1  -  -  14.6  1 
Singapore Singapore 
NHS92 
1992    3305  39.2  52  48 15 35 3  12 0  -  -  6.2  3 
S.  Korea  KMIC  1992  160242 44.0  33 73 9 58 0 21 0  -  -  4.0  49 
Taiwan  CVDFACTS 1988-96  5729 47.2  55 16  1 48    1 7 0  -  -  6.0  2 
Taiwan  Kinmen  1993-97  2545 63.2  49 44 4 50 5 17 1  -  -  2.9  6 
Asia  Subtotal  1961-98 398045 44.6  32 49 9 59 5 11 1 15 11  5.3  274 
Total    1961-99 455409 46.0  32 53  17  55 7 14 3 16 14  5.9  371 Int. J. Environ. Res. Public Health 2009, 6          
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Figure 1. Hazard ratios for death due to upper aero digestive tract cancer for current 
smokers compared with those who have never smoked by subgroups and overall.  
 
 
Black square = point estimate (with area proportional to statistical ‘information’, based on inverse 
of variance of the HR estimated for each subgroup) and horizontal line = 95% CI for observed 
effect in each subgroup and overall.  
1 = adjusted for age and alcohol (analyses from Cox models which were stratified by sex and 
study); 
2 = adjusted for age (stratified by sex and study); 
3 = adjusted for age and alcohol (stratified by study); 
4 = adjusted for age and alcohol (stratified by sex and study) 
 
2.2. Current Drinking and Smoking and UADTC 
 
The HR for current drinking, compared with not, was 1.33 (95% CI: 1.03 – 1.73). However, after 
adjusting for current smoking, alcohol had very little association with the risk of mortality from 
UADTC: 1.01 (95% CI: 0.80 – 12.7). Current smoking had a significant effect among both drinkers 
and non-drinkers (Figure 1). Although the effect of smoking was considerably higher among those 
who consumed alcohol, there was no strong evidence of an interaction (p = 0.10), perhaps due to lack 
of information on the level of alcohol consumption.  Int. J. Environ. Res. Public Health 2009, 6          
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2.3. Smoking and Risk of Mortality from UADTC in Former Smokers 
 
Overall, 48,134 individuals (62% from Asia) reported at study baseline that they had quit smoking. 
During follow-up, a total of 70 (40% from Asia) former smokers died of UADTC. The HR for 
mortality from UADTC, comparing ex-smokers with current smokers, was 0.92 (95% CI: 0.66 – 1.27), 
adjusted for age and alcohol drinking. This HR differed by subtypes of UADTC: for lip, oral cavity or 
pharyngeal cancer, 0.99 (95% CI: 0.58 – 1.69); esophageal cancer, 1.03 (95% CI: 0.66 – 1.63); and 
laryngeal cancer, 0.33 (95% CI; 0.11 – 0.98). 
 
Table 2. Dose-response association between current cigarette smoking and upper aero 
digestive tract cancers (CPD=cigarettes currently smoked per day, where known). All 
analyses stratified by sex and study. 
Cancer type 
No. of 
subjects 
No. of 
deaths 
Adjusted for age  
 HR and 95 % CI 
Adjusted for age & alcohol 
HR and 95 % CI 
Lip, oral cavity or pharynx    
Never-smoked    142700  57  1  1 
<20 CPD  50077  34  1.83 (1.14-2.95)  1.86 (1.15-3.00) 
≥20 CPD  38785  43  2.32 (1.47-3.65)  2.37 (1.49-3.78) 
P for trend  <0.001  <0.001 
Esophagus    
Never-smoked    142700  33  1  1 
<20 CPD  50077  17  2.74 (1.37-5.49)  2.52 (1.25-5.07) 
≥20 CPD  38785  25  3.89 (1.99-7.60)  3.40 (1.71-6.76) 
P for trend  <0.001  <0.001 
Larynx    
Never-smoked    142700  7  1  1 
<20 CPD  50077  2  1.18 (0.22-6.17)  1.28 (0.24-6.76) 
≥20 CPD  38785  9  5.25 (1.62-17.0)  5.91 (1.81-19.3) 
P for trend  0.005  0.003 
Overall        
Never-smoked    142700  97  1  1 
<20 CPD  50077  53  2.03 (1.38-2.97)  2.01 (1.37-2.95) 
≥20 CPD  38785  77  2.88 (2.01-4.11)  2.83 (1.96-4.09) 
P for trend  <0.001  <0.001 
 
2.4. Dose-Response Relationship between Current Smoking and UADTC 
 
Of the 26 studies, 17 reported the number of cigarettes smoked per day at baseline, involving 
231,562 study participants. There was evidence of a dose-response association between the number of 
cigarettes smoked per day and mortality from UADTC and its subtypes (Table 2). Individuals who 
smoked more than 20 cigarettes a day had approximately three times the risk of dying from UADTC Int. J. Environ. Res. Public Health 2009, 6          
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compared with never smokers. However, there was evidence of a sex difference in the strength of this 
association: the HR for smoking > 20 cigarettes per day compared with never smoking was 2.27  
(95% CI: 1.77 – 2.90) in men versus 21.1 (95% CI: 9.02 – 49.4) in women, after adjusting for age and 
alcohol; (Figure 2A). Similarly, significant differences were found between the regions (Figure 2B); 
the equivalent HRs were 5.03 (95% CI: 2.70 – 9.36) in ANZ versus 2.30 (95% CI: 1.77 – 2.99) in 
Asia. 
 
Figure 2. Hazard ratios for death due to upper aero digestive tract cancer for current 
smokers by number of cigarettes smoked per day, compared with those who have never 
smoked. Lines show 95% confidence limits; the arrow signifies that the upper end is off the 
scale. Hazard ratios are adjusted for age and alcohol.  
(a) Analyses by sex (stratified by study) 
 
(b) Analyses by region (stratified by sex and study) 
 Int. J. Environ. Res. Public Health 2009, 6          
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2.5. Contribution of Smoking to Mortality from UADTC 
 
Figure 3 presents the population attributable fraction for males and females for UADTC caused by 
smoking for each country in the WHO Western Pacific and South-East Asian regions. The fraction of 
UADTC attributable to smoking ranged from 18-47% in males and from 1-45% in females. 
 
2.6. Discussion 
 
Analyses from this large dataset, with almost 400 deaths, confirm that smoking is strongly 
associated with the risk of mortality from UADTC in both Asia and ANZ. There was a significant 
dose-response association between the average number of cigarettes smoked daily and the risk for all 
subtypes of UADTC. Smoking had a stronger association with the risk of mortality from UADTC 
among female, compared with male, smokers. Although not statistically significant, the current study 
supports previous observations that concurrent alcohol consumption may exacerbate the effect of 
smoking on the risk of UADTC [7,14]: amongst non-drinkers, smoking doubled the risk of UADTC, 
whereas amongst drinkers it trebled the risk. 
 
The findings of this study are consistent with earlier epidemiological evidence [15-23], but the 
estimated hazards are smaller than in some studies [18-23], especially those conducted in Western 
countries [20-23]. This may be due to differences in study design and the degree to which non-fatal 
events are included. But it may also signify a regional difference, since the Asian studies contributed 
87% of participants, and 74% of events in APCSC, whilst the ANZ hazard ratio was significantly 
higher in this study. The lower excess risk for UADTC associated with smoking in Asia is likely to be 
due to the relative immaturity of the smoking epidemic across Asian countries [24], especially in 
China, where the habit only reached its peak in the mid-1990’s [25-29]. Other potential contributing 
factors to the smaller relative risks associated with smoking observed in the Asian cohorts are the 
greater exposure among non-smokers to indoor air-pollution from wood-burning in homes [30] 
combined with extremely high levels of passive smoking, particularly in China where an estimated 450 
million individuals are so exposed [31].  
The APCSC estimates suggest a greater risk of mortality from UADTC among female smokers 
compared with male smokers, in agreement with a recent study in Japan [32], but opposite to the 
finding of the Swedish Smoking Survey [33],
 although the latter was based on few events (11 in 
women and 33 in men). Several epidemiological studies have found a statistically significant increase 
risk for lung cancer among female smokers compared with male smokers, although others have found 
no difference [34-39]. It is currently unclear which mechanisms mediate the reported increased 
susceptibility among female smokers to cancers of the lung and upper-aero digestive tract. Potential 
explanations include sex differences in smoking behaviours (such as the degree of inhalation, for 
example) or differences in the accuracy of self-reporting of smoking consumption between men and 
women. Alternatively, a role for female sex hormones in increasing the susceptibility of women to 
tobacco carcinogens has been suggested [34-38]. Clearly, further research is required to determine 
whether the difference in risk between men and women is real and if so, what is driving it. Answers to 
these two questions could have repercussions for the development of sex-specific smoking cessation Int. J. Environ. Res. Public Health 2009, 6          
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programs, particularly in countries where the prevalence of smoking is on the increase in young 
women [40].  
 
Figure 3. Population attributable risk (%) of upper aero digestive tract cancer for smoking. 
Data are derived from representative surveys (years of studies given in parentheses). 
 
In contrast with an overview of studies that reported a reduction in risk of UADTC among former 
smokers compared with current smokers of 30% to 50% in the first five years and up to 70% after 10 
years of quitting smoking [41], data from the current study failed to demonstrate a significant 
reduction in risk of dying from UADTC among former smokers compared with current smokers, 
except for laryngeal cancer. We believe that our inability to find a protective effect of quitting overall 
is most likely an artifact of the current situation in Asia where quitting is unusual, and those who have 
quit will have abstained for a relatively short time. However, differences in the distribution of 
subsidiary site cancers within the overall definition of UADTC could also play a role.
 
The main strength of the current analysis is the large number of events, which facilitated our ability 
to assess associations in subgroups. However, we were limited by lack of information on duration of Int. J. Environ. Res. Public Health 2009, 6          
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smoking and age of uptake of smoking, which may well be important determinants of the risk of 
smoking cigarettes for UADTC. Our data on alcohol drinking were also limited to baseline measures 
of current drinking and also to whether or not the subject drank; there is evidence [7,14] of a dose-
response relationship between the amount of alcohol consumed and UADTC. Thus, we may have 
underestimated the true effect of drinking; there may be residual confounding due to our lack of data 
on the frequency of alcohol use. Furthermore, we had no data on changes in smoking and drinking 
status during follow-up. Although our analyses were restricted to deaths, the low five-year survival 
from UADTC [2-4], and the lack of systematic differences in excess risk found between previous 
studies that did [15,16,18,21-23] and did not [17,19,20] analyse non-fatal, as well as fatal, UADTC 
events, suggests that this has not introduced bias. 
 
3. Conclusions 
 
Findings from this study have clear implications for public health. For example, based on recent 
reports of the prevalence of smoking amongst men [10], and the effect of smoking found here, we 
estimate that 38% of male deaths from UADTC in China are attributable [13] to smoking. Effective 
tobacco control in the populous Asia Pacific region should prevent millions of deaths from UADTC, as 
well as other smoking-related outcomes, over the next few decades.  
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